RESORCINOL, 2-(3,7-DIMETHYL-2,6-OCTADIENYL)-5-PENTYL-, (E)-
Overuse Headache Medication
Hospital Israelita Albert EinsteinSmall moleculePhase 2/3Active
CCC
55/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Overuse Headache Medication cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
RESORCINOL, 2-(3,7-DIMETHYL-2,6-OCTADIENYL)-5-PENTYL-, (E)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →